Every AI newsletter, investors ask on the investor interaction platform: in recent years, scientific research on gene editing and therapy has made rapid progress. Does the company have any plans or layout in this direction?
Berry Genomics Co.Ltd(000710) (000710. SZ) said on the investor interaction platform on February 25 that the company has not been involved in relevant fields yet.
